Background: Collaboration between providers of conventional care and complementary therapies (CTs) has gained in popularity but there is a lack of conceptualised models for delivering such care, i.e. integrative medicine (IM). The aim of this paper is to describe some key findings relevant to the development and implementation of a proposed model for IM adapted to Swedish primary care.
coli are also important potential pathogens after splenectomy.' We report two recent deaths from fulminant meningococcal septicaemia in people in Western Australia who had undergone splenectomy.The first patient was a 36 year old woman who had a splenectomy at the age of 30 for spontaneous rupture of the spleen during the third trimester of pregnancy. She had mild upper respiratory symptoms for four days and then collapsed suddenly; she died four hours later. Blood cultures subsequently grew N meningitidis serogroup W135.The second patient was a 16 year old girl, who was not related to the previous patient. She had had a splenectomy during childhood for hereditary spherocytosis. She initially presented to her local hospital with fever and symptoms suggestive of tonsillitis with bacteraemia. Her condition deteriorated rapidly, and she was evacuated to Perth for intensive care but died the next day. N meningitidis was cultured from her blood and cerebrospinal fluid and yielded a positive result on testing with serogroup XYZW135 polyvalent antiserum.The adult woman had received neither pneumococcal nor meningococcal vaccines, while the 16 year old girl had received one dose of pneumococcal vaccine since her splenectomy. Tetravalent ACYW meningococcal vaccine is now available in many countries. It is used in Britain for immunoprophylaxis of close contacts of an index patient with invasive disease caused by serogroup A, C, Y, or W135 of N meningitidis,4 and a similar policy is being considered by an advisory panel to Australia's National Health and Medical Research Council.The two cases we report here emphasise the importance of offering tetravalent meningococcal vaccine (in addition to polyvalent pneumococcal vaccine) to patients who have had a splenectomy.Information on when to offer revaccination is scarce, but the duration of protection against disease provided by meningococcal vaccine' suggests that an interval of five years would be appropriate, and this would coincide with revaccination with pneumococcal vaccine.4 Immunisation with one of the H influenzae type b conjugate vaccines should also be considered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.